Covered recipient · General Payments record
TOMAS MARTINEZ
General Payments · PY2022–2024
$1,371.55
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $742.90 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $227.39 | 2 |
| UCB, Inc. | $162.61 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $140.33 | 2 |
| E.R. Squibb & Sons, L.L.C. | $122.79 | 1 |
| TG THERAPEUTICS, INC. | $89.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $122.79 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101742885 | CMS |
| GlaxoSmithKline, LLC. | $104.60 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116522534 | CMS |
| GlaxoSmithKline, LLC. | $122.79 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116564918 | CMS |
| Novartis Pharmaceuticals Corporation | $116.72 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087151414 | CMS |
| Novartis Pharmaceuticals Corporation | $23.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087151398 | CMS |
| TG Therapeutics, Inc. | $89.78 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136881145 | CMS |
| UCB, Inc. | $1.77 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324322 | CMS |
| UCB, Inc. | $22.97 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324326 | CMS |
| UCB, Inc. | $18.67 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324330 | CMS |
| UCB, Inc. | $102.09 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324335 | CMS |
| UCB, Inc. | $1.66 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324339 | CMS |
| UCB, Inc. | $15.45 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324343 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.